1. Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively

   • Samuel R. Chamberlain
   • David S. Baldwin

   Therapy in Practice 09 July 2021 Pages: 703 - 716

   

2. The Effect of Statin Treatment on Outcomes of Cardioembolic Stroke: A Systematic Review and Meta-Analysis of Real-World Studies

   • Tao Xu
   • You Wang
   • Yangmei Chen

   Systematic Review 21 May 2021 Pages: 717 - 726

   

3. Relevance of 5-HT_2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy

   • Ethan S. Burstein

   Review Article Open access 05 July 2021 Pages: 727 - 741

   

4. Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)

   • Stanley L. Cohan
   • Barry A. Hendin
   • Bianca Weinstock-Guttman

   Review Article Open access 06 July 2021 Pages: 743 - 767

   

5. Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study

   • Le Gao
   • Kenneth K. C. Man
   • Ian C. K. Wong

   Original Research Article Open access 20 July 2021 Pages: 769 - 779

   

6. Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies

   • Richard L. Doty
   • Vanina Popova
   • Wayne C. Drevets

   Original Research Article Open access 07 July 2021 Pages: 781 - 794

   

7. Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison

   • Stanley Cohan
   • Jinender Kumar
   • Tom Tencer

   Original Research Article Open access 13 April 2021 Pages: 795 - 804